CELH
Celsius Holdings, Inc.
CELH has the edge over HRL overall, supported by stronger fundamentals and stronger valuation.
HRL
Hormel Foods Corporation
HRL's outlook is improving, though it still trails on the overall score.
CELH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Strong |
CELH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
HRL Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Stable |
HRL's cash flow is currently healthy, and its revenue, profitability and balance sheet are stable.
CELH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $31.89 | — |
| Current | 35x | $31.89 | — |
| Cheap | 40x | $35.95 | +13% |
| Fair | 141x | $127 | +299% |
| Expensive | 650x | $585 | +1735% |
Historical ranges are pointers, not guarantees.
CELH has the edge over HRL in the historical PE scenario, which offers more potential upside but is not a forecast.
HRL PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 14x | $21.83 | — |
| Cheap | 22x | $13.75 | -37% |
| Fair | 25x | $15.90 | -27% |
| Expensive | 29x | $18.34 | -16% |
| Current | 35x | $21.83 | — |
Historical ranges are pointers, not guarantees.
HRL's PE is in its expensive range at 35x. If earnings grow as analysts expect, today's price would be 14x next year's earnings, in its cheap range.
CELH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
CELH has the edge over HRL on the outlook, with more favorable revenue expectations.
HRL Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Stable | |
| Improving | |
| Limited | |
| High |
Analysts expect HRL's earnings to grow and its profitability to improve, with its revenue holding steady.
CELH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.53 | +70% |
| Q3 2026 | $0.90 | +718% |
| Q2 2026 | $0.24 | -37% |
| Q1 2026 | $0.43 | +30% |
| Q4 2025 | $0.25 | -44% |
| Q3 2025 | $0.11 | -85% |
| Q2 2025 | $0.38 | -62% |
| Q1 2025 | $0.33 | -64% |
| Q4 2024 | $0.45 | -42% |
CELH earned $0.90 per share over the past year, about eight times what it earned the year before.
HRL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.57 | +149% |
| Q3 2026 | $0.63 | -54% |
| Q2 2026 | $0.85 | -38% |
| Q1 2026 | $0.89 | -36% |
| Q4 2025 | $0.87 | -41% |
| Q3 2025 | $1.38 | -2.1% |
| Q2 2025 | $1.37 | -1.4% |
| Q1 2025 | $1.38 | -4.8% |
| Q4 2024 | $1.47 | +1.4% |
HRL's earnings per share have fallen from their peak: $0.63 over the past year, against $1.83 in mid-2022.
CELH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $847.2M | +17% |
| Q2 2026 | $817.9M | +11% |
| Q1 2026 | $782.6M | +138% |
| Q4 2025 | $721.6M | +117% |
| Q3 2025 | $725.1M | +173% |
| Q2 2025 | $739.3M | +84% |
| Q1 2025 | $329.3M | -7.4% |
| Q4 2024 | $332.2M | -4.4% |
CELH has the edge over HRL on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +31 points |
| Q2 2026 | 9.2% | -10 points |
| Q1 2026 | 18% | +2 points |
| Q4 2025 | 3.6% | +9.2 points |
| Q3 2025 | -11% | -9.8 points |
| Q2 2025 | 19% | -4.1 points |
| Q1 2025 | 16% | -7.6 points |
| Q4 2024 | -5.6% | -23 points |
CELH has the edge over HRL on profitability, with a higher operating margin.
HRL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $3B | -2.4% |
| Q2 2026 | $3B | +2.5% |
| Q1 2026 | $3B | +1.3% |
| Q4 2025 | $3.2B | +1.5% |
| Q3 2025 | $3B | +4.6% |
| Q2 2025 | $2.9B | +0.4% |
| Q1 2025 | $3B | -0.3% |
| Q4 2024 | $3.1B | -1.9% |
HRL's revenue grew through 2021 and has held roughly level since: $3B last quarter, down 2.4% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 3.8% | -4.2 points |
| Q2 2026 | 7.3% | -1.3 points |
| Q1 2026 | 8.1% | +0.4 points |
| Q4 2025 | 0.1% | -9.3 points |
| Q3 2025 | 7.9% | -0.3 points |
| Q2 2025 | 8.6% | -0.2 points |
| Q1 2025 | 7.6% | -1.9 points |
| Q4 2024 | 9.4% | +0.9 points |
HRL's operating margin was 3.8% last quarter, down 4.2 points from the same quarter a year ago, near the bottom of its range since 2019.
CELH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $127.7M | -60% |
| Q2 2026 | $205.5M | +479% |
| Q1 2026 | $65.8M | -32% |
| Q4 2025 | -$130M | -285% |
| Q3 2025 | $321.5M | +3599% |
| Q2 2025 | $35.5M | +17% |
| Q1 2025 | $96.4M | -26% |
| Q4 2024 | $70.3M | +16394% |
CELH still generates free cash flow, though less than at its 2025 peak: $269M over the past year.
HRL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $172.4M | +104% |
| Q2 2026 | $96.8M | +$115.4M |
| Q1 2026 | $280.2M | +18% |
| Q4 2025 | $231.4M | -29% |
| Q3 2025 | $84.5M | -45% |
| Q2 2025 | -$18.6M | -111% |
| Q1 2025 | $237M | -34% |
| Q4 2024 | $324.8M | +49% |
HRL generated $781M in free cash flow over the past year, up 24% from the year before.
CELH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -2M shares |
| 1 year | -1.1% | -2.9M shares |
| 3 years | +7.4% | +17.6M shares |
| 5 years | +8.3% | +19.5M shares |
| Available history | +32% | +62.4M shares |
CELH has the edge over HRL on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $300,000 |
| Q2 2026 | $1M |
| Q1 2026 | $8.8M |
| Q4 2025 | $2.5M |
| Q3 2025 | $448,000 |
| Q2 2025 | $879,000 |
| Q1 2025 | $1.9M |
| Q4 2024 | $603,000 |
CELH spent $13M buying back its own shares over the past year, about three times what it spent the year before.
HRL Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +159K shares |
| 1 year | +0.1% | +351K shares |
| 3 years | +0.4% | +2.4M shares |
| 5 years | +0.5% | +3M shares |
| Available history | +1.1% | +5.8M shares |
HRL has 551M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q4 2024 | — |
| Q3 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | — |
| Q1 2022 | — |
CELH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -7.3x | Net Cash |
| Q4 2024 | -5.5x | Net Cash |
CELH has the edge over HRL on leverage, with a lower net debt burden relative to earnings.
HRL Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.4x | Moderate |
| Q2 2026 | 2.1x | Moderate |
| Q1 2026 | 2.0x | Healthy |
| Q4 2025 | 2.2x | Moderate |
| Q3 2025 | 1.8x | Healthy |
| Q2 2025 | 1.7x | Healthy |
| Q1 2025 | 1.6x | Healthy |
| Q4 2024 | 1.6x | Healthy |
HRL's net debt is about 2.4 years of its operating earnings (EBITDA), up from 1.8 years a year ago.
CELH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 56.8 | Neutral |
CELH's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).
HRL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 48.0 | Neutral |
| Stochastic | 41.3 | Neutral |
HRL's weekly RSI is 48 (neutral) and its Stochastic is 41 (neutral).
CELH PE vs Consumer Defensive Sector
| Metric | CELH | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 19x | 82% above |
| PE % | 11 | 18 | 7 pts below |
CELH is trading at 35x earnings, a 82% premium to the Consumer Defensive sector's median of 19x.
HRL PE vs Consumer Defensive Sector
| Metric | HRL | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 19x | 78% above |
| PE % | 100 | 18 | 82 pts above |
HRL has the edge over CELH on valuation relative to its sector.
CELH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.1 | 9.4% above |
| 20 week MA | $29.6 | 7.8% above |
| 50 week MA | $36.1 | 12% below |
| 100 week MA | $38.8 | 18% below |
| 200 week MA | $44.6 | 29% below |
CELH has the edge over HRL on trend strength, trading above more of its moving averages.
HRL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $20.7 | 5.4% above |
| 20 week MA | $22.5 | 2.8% below |
| 50 week MA | $23.0 | 4.9% below |
| 100 week MA | $25.6 | 15% below |
| 200 week MA | $30.5 | 28% below |
HRL has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 28% below its 200-week average.
CELH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.58 | $14.7 | +832% |
| 2021 | $14.7 | $24.9 | +69% |
| 2022 | $24.9 | $35.6 | +43% |
| 2023 | $35.6 | $54.5 | +53% |
| 2024 | $54.5 | $26.5 | -51% |
| 2025 | $26.5 | $45.6 | +72% |
| 2026 YTD | $45.6 | $31.9 | -30% |
CELH's yearly returns have swung widely, from +832% in 2020 to −51% in 2024. It's down 30% so far in 2026.
HRL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $45.3 | $47.2 | +4.2% |
| 2021 | $47.2 | $47.8 | +1.3% |
| 2022 | $47.8 | $45.6 | -4.5% |
| 2023 | $45.6 | $32.1 | -30% |
| 2024 | $32.1 | $31.9 | -0.8% |
| 2025 | $31.9 | $24.3 | -24% |
| 2026 YTD | $24.3 | $21.8 | -10% |
HRL has the edge over CELH on returns for 2026, with the stronger performance.